Related Experiment Video
Updated: May 9, 2026
07:59
Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
European randomized lung cancer screening trials: Post NLST
John K Field1, Rob van Klaveren, Jesper H Pedersen
1The University of Liverpool Cancer Research Centre, Liverpool, UK.
Journal of Surgical Oncology
|July 30, 2013
Summary
European randomized lung cancer CT screening trials (EUCT) are being implemented across Europe. Final mortality data from these trials, involving over 36,000 participants, is anticipated in 2015.
Area of Science:
- Pulmonology
- Oncology
- Radiology
Background:
- The European randomized lung cancer CT screening trials (EUCT) were initiated following the NLST study.
- Implementation of CT screening for lung cancer in Europe is a key focus.
Purpose of the Study:
- To provide an overview of the EUCT implementation in Europe.
- To gather data on epidemiological, radiological, and nodule management aspects of ongoing trials.
Main Methods:
- A questionnaire was completed by principal investigators of seven major EUCT trials.
- Data collected in August 2010 included 32,000 participants, with the UKLS pilot trial expanding the cohort to 36,000.
Main Results:
- The overview details the epidemiological, radiological, and nodule management strategies within the EUCT.
- Interim analysis is planned, with final mortality data expected in 2015.
Conclusions:
- The EUCT represent a significant collaborative effort in lung cancer screening in Europe.
- The trials are crucial for evaluating the effectiveness and implementation of CT screening.